News Conference News CX Symposium 2025 Cost Surprises and Delayed Care in Women: BASIL-2 and BEST-CLI L.A. McKeown April 30, 2025
News Conference News HRS 2025 CRT Patients Fare Better With LBB Area vs Biventricular Pacing Todd Neale April 30, 2025
News Daily News Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN Yael L. Maxwell April 29, 2025
News Conference News HRS 2025 VANISH2 Bolsters Data Backing VT Ablation in Ischemic Cardiomyopathy Todd Neale April 29, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Daily News Medicaid Patients With Type 2 Diabetes Face Hurdles Getting Cardioprotective Meds Michael O'Riordan April 25, 2025
News Conference News CX Symposium 2025 Plant-Derived Compound Shows Early Promise for Small AAAs L.A. McKeown April 25, 2025
News Daily News LuX-Valve TTVR Device Provides Favorable 1-Year Results Yael L. Maxwell April 24, 2025
News Conference News CX Symposium 2025 Bioresorbable Scaffold for CLTI Appears to Be an Economical Option: LIFE-BTK L.A. McKeown April 24, 2025
News Daily News HRS, ACC Lay Out Principles for Same-Day Discharge After Catheter Ablation Todd Neale April 24, 2025
News Conference News CX Symposium 2025 Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices L.A. McKeown April 23, 2025
News Daily News Early Combo Therapy With Ezetimibe Lowers MACE Risk After MI Michael O'Riordan April 22, 2025
News Conference News HVS 2025 Solid Durability Seen With Surgical Resilia Tissue Aortic Valve Yael L. Maxwell April 21, 2025
News Daily News Black Adults Face CV Mortality Beyond Their Predicted Risk Caitlin E. Cox April 18, 2025
News Daily News High-Sensitivity Troponin Tests Might Aid in Primary Prevention Yael L. Maxwell April 16, 2025
News Daily News Mavacamten Strikes Out in Phase III Trial of Nonobstructive HCM L.A. McKeown April 15, 2025
News Daily News Topline Data Point to Promise for VERVE-102 Gene-Editing Therapy Caitlin E. Cox April 14, 2025
News Conference News ACC 2025 ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a) L.A. McKeown April 10, 2025